Amicus Education

  • Home
  • About Fabry
    • Fabry disease pathophysiology and natural history
    • Prevalence of Fabry disease
    • GLA gene variants and inheritance
    • Clinical manifestations of Fabry disease
    • Diagnosis of Fabry disease
    • Genetic testing for Fabry disease
    • Management of Fabry disease
  • About Pompe
    • Pompe disease pathophysiology and natural history
    • Prevalence of Pompe disease
    • GAA gene variants and inheritance
    • Clinical manifestations of Pompe disease
    • Diagnosis of Pompe disease
    • Genetic testing for Pompe disease
    • Management of Pompe disease
  • Your Specialty
    • Nephrology
      • Renal pathophysiology in Fabry disease
      • When should a nephrologist suspect Fabry disease
      • Management of Fabry disease
    • Cardiology
      • Cardiac pathophysiology in Fabry disease
      • When should a cardiologist suspect Fabry disease
      • Management of Fabry disease
    • Neuropsychology and ophthalmology
      • Pathophysiology and progression in Fabry disease
      • Neurology and Fabry disease
      • Psychology and Fabry disease
      • Ophthalmology and Fabry disease
      • When should you suspect Fabry disease?
      • Management of Fabry disease
    • Respiratory
      • Respiratory pathophysiology in Pompe disease
      • When should a respiratory specialist suspect Pompe disease?
      • Management of Pompe disease
    • Neurology
      • Pathophysiology of muscle damage
      • When should a neurologist suspect Pompe disease?  
      • Management of Pompe disease
  • Resources
    • All Resources
    • Latest Blog
  • Find a specialist centre

Genetic testing for Pompe disease

About Pompe disease

Genetic testing for Pompe disease

What to do before a genetic test

Genetic testing is typically reserved for patients with unexplained clinical feature(s) and/or a family history that may allude to a genetic explanation, or for individuals that are deemed ‘high-risk’ because of an identified pathogenic variant in their family.1 In the context of Pompe disease, either scenario can necessitate a genetic test, although clinicians may first seek to establish a deficiency in GAA enzyme activity through an enzyme assay.2

If a physical examination presents with unexplained symptoms, the first step is to obtain a detailed medical family history. This should include drawing a three-generation family tree (genetic pedigree).3

The next step is to consult the genetic test directory for the nation in which you are working. Test directories for Ireland, Wales, Scotland and Northern Ireland can be accessed using these links.

Genomic testing in Ireland

Genomic testing in the devolved nations

In England, clinicians should refer to the National Genomic Test Directory. This directory provides a comprehensive list of the genetic tests commissioned by the NHS (in England), allowing specialists to find information about the genetic tests available, the eligibility of their patient, which specialty can request the test and the correct steps for ordering a test.4 

The Genomics England PanelApp is another useful tool that helps specialists understand which genes are being investigated in each panel.

The GAA gene for Pompe disease is included in nine panels.5 Click on the heading to reveal the full list.

  • R419 Acute rhabdomyolysis
  • DDG2P: Paediatric disorder Super Panel
  • R21, R412 Fetal anomalies
  • R274 Glycogen storage disease
  • R276 Lysosomal storage disorder
  • R98 Likely inborn error of metabolism
  • R82 Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
  • R135 Paediatric or syndromic cardiomyopathy
  • Rhabdomyolysis and metabolic muscle disorders: Hypotonic infant and Other rare neuromuscular disorders Super Panels.

Although many of these panels are designed for infant-onset Pompe disease, some may be used for late-onset Pompe disease, depending on the presentation.

For example, let’s say a patient presents with progressive myopathy and a history of fatigue and shortness of breath. This leads to a suspicion of a muscular dystrophy or an overlapping condition, so the clinician decides that genomic testing is warranted. The clinician goes on to refer the patient for the R82 panel which includes GAA.4,6

Consent and counselling

When undertaking genetic testing, it is the responsibility of the referring specialist to record any discussions with the patient and obtain informed consent. This can be documented in the patient notes, but best practice is to complete a Record of Discussion (RoD) form.7

Pre-genetic test counselling may also be necessary, as it ensures patients are informed about the test itself, and what the results might mean.8

Arranging a genetic test

Genetic test requests are submitted using a Genetic Testing Request Form. The form will specify any sampling requirements and provide prompts for all necessary information.9 Forms will vary by trust and are available on local Genomic Laboratory Hub websites.

The turnaround time for the results varies, ranging from a few weeks for a single gene test to several months, depending on test complexity and lab workload. The laboratory will be able to advise on the likely turnaround time.9

Interpreting the results

There are four possible findings for any diagnostic genetic test, which are summarised below.10 Click on the headings to find out more.

A pathogenic or likely pathogenic variant(s) consistent with the patient’s condition is identified.10 In the case of Pompe disease, a pathogenic GAA variant is identified.

A variant is discovered but is unrelated to the reason for requesting the genetic test.10

No significant variant(s) associated with the patient’s condition is identified. However, this result is reliant on current knowledge and understanding, so it does not necessarily mean that the individual does not have an underlying genetic cause for their condition. In these instances, clinical management depends on the patient’s clinical and/or family history.

A variant is identified, however there is insufficient information to confirm whether the variant identified is natural genomic variation or is relevant to the patient’s condition. No conclusions can be made.10 Variants can be reclassified over time as more data become available.

The results of a genetic tests are typically returned to the requesting clinician by post or email. They are then shared with the patient at the start of their next appointment, once they have confirmed they are ready to hear them.

Results should be stated in clear, simple terms. It is important to remember that a genetic test result (such as a Pompe disease diagnosis) can provoke a range of emotions and can have a large impact, both positive and negative, on family members.

If a Pompe disease diagnosis is established, family members may wish to undergo carrier testing, as Pompe is inherited in an autosomal recessive manner.

The local clinical genetics service may be contacted:9

for any patient in whom a genetic diagnosis is made

for any patient in whom a variant of uncertain significance is found, as there may be further investigations that can be offered

if there is uncertainty surrounding the patient’s eligibility for a genetic test

if the test the patient is eligible for is not open to anyone outside clinical genetics

for any predictive testing (e.g. testing an asymptomatic individual or family member)

if the patient wants a more in-depth discussion before having testing

If you diagnose an individual with Pompe disease, you should refer them to a nominated ultra-specialist centre for further support and to access disease-specific therapies. Please refer to our ‘Find a specialist centre’ page to find out more.

Learn more

Click here to access a downloadable checklist for diagnostic genetic testing.

Com-NN-UKI-26-00019
May 2026

  1. NHS. Genetic and genomic testing. March 2023. Available at: https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/. Accessed: May 2026.
  2. Muscular Dystrophy Association (MDA). Genetic Testing Options for Pompe Disease. 2021. Available at: https://www.mda.org/sites/default/files/2022/11/Genetic-Testing-Options-for-Pompe-Disease.pdf. Accessed: May 2026.
  3. NHS Genomics Education Programme. Taking and drawing a family history. Available at: https://www.genomicseducation.hee.nhs.uk/taking-and-drawing-a-family-history/. Accessed: May 2026.
  4. NHS England. National genomic test directory. August 2025. Available at: https://www.england.nhs.uk/publication/national-genomic-test-directories/. Accessed: May 2026.
  5. Genomics England. GAA. PanelApp. Available at: https://nhsgms-panelapp.genomicsengland.co.uk/entities/GAA. Accessed: May 2026.
  6. Genomics England. R82 Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies. 2025. Available at: https://nhsgms-panelapp.genomicsengland.co.uk/panels/185/v5.0. Accessed: May 2026.
  7. NHS England. How to complete a record of discussion form. October 2025. Available at: https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/how-to-complete-a-record-of-discussion-form/. Accessed: May 2026.
  8. European Society of Cardiology. Genetic counselling: When and Why? June 2024. Available at: https://www.escardio.org/Councils/Council-on-Cardiovascular-Genomics/Cardiovascular-Genomics-Insight/Volume-10/Genetic-counselling-When-and-Why. Accessed: May 2026.
  9. Leeds Teaching Hospitals NHS Trust. Requesting genetic testing: A brief summary for all specialities. October 2025. Available at: https://www.leedsth.nhs.uk/services/pathology/clinical-genetics/resources-for-health-professionals/requesting-genetic-testing-a-brief-summary-for-all-specialities/. Accessed: May 2026.
  10. NHS Genomics Education Programme. Four types of genomic testing explained. May 2019. Available at: https://www.genomicseducation.hee.nhs.uk/blog/four-types-of-genomic-testing-explained/. Accessed: May 2026.

5.
Diagnosis of Pompe disease

7.
Management of Pompe disease

This non-promotional website is intended for UK Healthcare Professionals only.

Footer

Amicus is committed to providing medical education for UK healthcare professionals. This website is a non-promotional site developed and funded by Amicus.

Menu
Home
About Fabry
About Pompe
Nephrology
Cardiology
Neuropsychology and Ophthalmology
Respiratory
Neurology
Resources
Find a Specialist Centre

Company
About Amicus

Help
Contact us

© Amicus Education 2026. All rights reserved | Amicus therapeutics UK LTD One Globeside, Fieldhouse Lane, Marlow SL7 7HZ United Kingdom | Company registration no. 05541527 | Com-NN-UKI-26-00011 | March 2026 Privacy policy | Cookie policy | Terms of use